Announcements Trials
Browse Landscape

Phase

Phase 2/3 2Phase 1/2 1Phase 1 1

Status

Completed 4

Sponsor Class

OTHER 25NETWORK 13NIH 7INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 1Extravasations of Anthracycline Anti-cancer Agents 1Extravasation 1Anthracycline Extravasation 1

Interventions

pembrolizumab 1029Carboplatin 966Paclitaxel 941Gemcitabine 798Cisplatin 754Docetaxel 697Bevacizumab 638Nivolumab 519Pemetrexed 507Capecitabine 475Cyclophosphamide 468Fluorouracil 424Dexamethasone 409Rituximab 391Oxaliplatin 351Injections 344Trastuzumab 313atezolizumab 311Cetuximab 291Leucovorin 288Irinotecan 269130-nm albumin-bound paclitaxel 255Prednisone 250Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 215durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Dexrazoxane × Clear all
NCT05858710 2025-07-28

Study of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma

Thermosome GmbH

Phase 1 Completed
8 enrolled
Sarcoma

Sarcoma

NCT00548561 2015-10-21

Efficacy of TopotectTM (Dexrazoxane) for Accidental Extravasation of Anthracyclines

Valerio Therapeutics

Phase 2/3 Completed
23 enrolled

Anthracycline Extravasation

NCT00548704 2015-10-21

A Clinical Trial on Topotect® (Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracyclines

Valerio Therapeutics

Phase 2/3 Completed
57 enrolled

Extravasation

NCT01596088 2015-04-07

A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents

Kissei Pharmaceutical Co., Ltd.

Phase 1/2 Completed
2 enrolled 6 charts

Extravasations of Anthracycline Anti-cancer Agents

Data powered by HemOnc (CC BY 4.0) Colophon âš¡